SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-003578
Filing Date
2021-11-09
Accepted
2021-11-09 08:10:55
Documents
14
Period of Report
2021-11-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20211109.htm   iXBRL 8-K 54132
2 EX-99.1 oncr-ex99_1.htm EX-99.1 24639
3 GRAPHIC img130253335_0.jpg GRAPHIC 4325
  Complete submission text file 0000950170-21-003578.txt   210793

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20211109_lab.xml EX-101.LAB 13896
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20211109_pre.xml EX-101.PRE 10220
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20211109.xsd EX-101.SCH 2472
7 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20211109_htm.xml XML 4880
Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 211389974
SIC: 2834 Pharmaceutical Preparations